<http://model.geneontology.org/551161095>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/-450760279>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/474607404> , <http://model.geneontology.org/531807246> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1587>
] .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/100934243> , <http://model.geneontology.org/158134085> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1577>
] .

<http://www.reactome.org/biopax/63/48887#Pathway1576>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.biopax.org/release/biopax-level3.owl#Pathway> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Galactose-1-phosphate uridylyltransferase (GALT) is one of the enzymes involved in galactose metabolism in the Leloir pathway. GALT catalyses the transfer of uridine monophosphate (UMP) from UDP-glucose (UDP-Glc) to galactose-1-phosphate (Gal1P) to form UDP-galactose (UDP-Gal) and glucose 1-phosphate. Defects in GALT can cause Galactosemia (GALCT; MIM:230400), an autosomal recessive disorder of galactose metabolism presenting in neonatals that causes jaundice, cataracts and mental retardation (Bosch 2006)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Defective GALT can cause Galactosemia" ;
        <http://geneontology.org/lego/hint/layout/x>
                1800 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: Jassal, Bijay, 2014-07-18" , "Reviewed: Timson, David J, 2015-02-25" , "https://reactome.org/content/detail/R-HSA-5609975" , "Authored: Jassal, Bijay, 2014-07-18" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/671120909>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/354647590>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/BFO_0000051>
        a       <http://www.w3.org/2002/07/owl#ObjectProperty> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has part" .

<http://model.geneontology.org/-311446616>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://www.reactome.org/biopax/63/48887#Pathway1583>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Phosphomannomutase 2 (PMM2) normally catalyses the isomerisation of mannose 6-phosphate (Man6P) to mannose 1-phosphate (Man1P) in the cytosol of cells. Man1P is a precursor in the synthesis of GDP-mannose and dolichol-phosphate-mannose, required for critical mannosyl transfer reactions in the N-glycosylation of proteins. Mutations in the PMM2 gene are one of the causes of Jaeken syndrome, a congenital disorder of glycosylation type 1a (PMM2-CDG, previously CDG-1a) (Matthijs et al. 1997). PMM2-CDG was first described in Belgian identical twin sisters, characterized by psychomotor retardation and multiple serum glycoprotein abnormalities. Serum and CSF transferrin were found to be deficient in sialic acid (Jaeken et al. 1984). PMM2-CDG is the most common CDG disease subtype." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Defective PMM2 causes PMM2-CDG (CDG-1a)" ;
        <http://geneontology.org/lego/hint/layout/x>
                7650 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Reviewed: Spillmann, Dorothe, 2015-04-30" , "https://reactome.org/content/detail/R-HSA-5609975" , "Edited: Jassal, B, 2013-07-29" , "Authored: Jassal, B, 2013-07-29" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/158134085>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002327>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "enables" .

<http://model.geneontology.org/-400805559>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.org/pav/providedBy>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://model.geneontology.org/-38379420>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/CHEBI_36080>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "chebi protein" .

<http://purl.obolibrary.org/obo/RO_0002406>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly activates (process to process)" .

<http://purl.obolibrary.org/obo/BFO_0000002>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Continuant" .

<http://purl.obolibrary.org/obo/GO_0008150>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Biological Process" .

<http://purl.obolibrary.org/obo/RO_0002334>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "regulated by" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/335293741> , <http://model.geneontology.org/278093899> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1586>
] .

<http://purl.obolibrary.org/obo/BFO_0000015>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Process" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/-38379420> , <http://model.geneontology.org/-95579262> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1576>
] .

<http://www.reactome.org/biopax/63/48887#Pathway1575>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0008150> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Cytosolic UDP-galactose 4'-epimerase (GALE) catalyses the reversible interconversion of UDP-D-galactose (UDP-Gal) and UDP-glucose (UDP-Glc), the third reacton in the Leloir pathway of galactose metabolism. GALE can also catalyse the epimerisation of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The active form of the enzyme is a homodimer with one molecule of bound NAD per monomer (GALE:NAD+ dimer). Defects in GALE can cause Epimerase-deficiency galactosemia (EDG; MIM:230350), or type III galactosemia (diseases of galactose metabolism) whose clinical features include early-onset cataracts, liver damage, deafness and mental retardation. Historically, it was considered that there were two forms of GALE deficidency; a benign (\"peripheral\") form where there is no GALE activity in red blood cells and characterised by mild symptoms (Gitzelmann 1972) and a rarer \"generalised\" form with no detectable GALE activity in all tissues resulting in more severe symptoms (Holton et al. 1981). The disease is now considered to be a continuum (Openo et al. 2006)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Defective GALE can cause Epimerase-deficiency galactosemia (EDG)" ;
        <http://geneontology.org/lego/hint/layout/x>
                6350 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" , "Edited: Jassal, Bijay, 2014-07-18" , "Reviewed: Timson, David J, 2015-02-25" , "Authored: Jassal, Bijay, 2014-07-18" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://www.reactome.org/biopax/63/48887#Pathway1588>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Sialidases have important roles in the degradation of glycoconjugates by removing terminal sialic acid residues.<br>Defects in sialidase 1 (NEU1) cause sialidosis, a lysosomal storage disease characterised by the progressive lysosomal storage of sialidated glycopeptides and oligosaccharides and the accumulation and excretion of N-acetylneuraminic acid (Neu5Ac) covalently-linked ('bound') glycoconjugates (Lowden & O'Brien 1979). The sialidoses are distinct from the sialurias in which there is storage and excretion of 'free' Neu5Ac. Sialidosis manifests into types I and II forms. Type I is the milder form, also known as the 'normosomatic' type or the cherry red spot-myoclonus syndrome. Sialidosis type II is the more severe form with an earlier onset, and is also known as the 'dysmorphic' type." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Defective NEU1 causes sialidosis" ;
        <http://geneontology.org/lego/hint/layout/x>
                4400 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: Jassal, B, 2013-08-21" , "Reviewed: Spillmann, Dorothe, 2015-04-30" , "https://reactome.org/content/detail/R-HSA-5609975" , "Edited: Jassal, B, 2013-08-21" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002234>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has output" .

<http://purl.obolibrary.org/obo/RO_0002413>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly provides input for (process to process)" .

<http://purl.obolibrary.org/obo/BFO_0000050>
        a       <http://www.w3.org/2002/07/owl#ObjectProperty> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "part of" .

<http://model.geneontology.org/335293741>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://www.reactome.org/biopax/63/48887#Pathway1582>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.biopax.org/release/biopax-level3.owl#Pathway> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Mannose 6-phosphate isomerase (MPI) normally isomerises fructose 6-phosphate (Fru6P) to mannose 6-phosphate (Man6P) in the cytosol. Man6P is a precursor in the synthesis of GDP-mannose and dolichol-phosphate-mannose, required for mannosyl transfer reactions in the N-glycosylation of proteins. Defects in MPI cause congenital disorder of glycosylation 1b (MPI-CDG, previously known as CDG1b,; MIM:602579), a multisystem disorder characterised by under-glycosylated serum glycoproteins (Schollen et al. 2000). Unlike PMM2-CDG (CDG1a), there is no neurological involvement with MPI-CDG. Instead, patients present predominantly with diarrhoea, failure to thrive and protein-losing enteropathy (Pelletier et al. 1986). MPI-CDG is one of two CDGs that can be treated with oral mannose supplementation, but can be fatal if left untreated (Marquardt & Denecke 2003)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Defective MPI causes MPI-CDG (CDG-1b)" ;
        <http://geneontology.org/lego/hint/layout/x>
                8950 , 10250 ;
        <http://geneontology.org/lego/hint/layout/y>
                6350 , 50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Reviewed: Spillmann, Dorothe, 2015-04-30" , "Authored: Jassal, B, 2013-07-29" , "Edited: Jassal, B, 2013-07-29" , "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/-234892925>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/GO_0032991>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Macromolecular Complex" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/BFO_0000002> .

<http://model.geneontology.org/-458005401>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/1350676965>
        a       <http://www.w3.org/2002/07/owl#Ontology> ;
        <http://geneontology.org/lego/modelstate>
                "development" ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/title>
                "Reactome::Diseases associated with glycosylation precursor biosynthesis" .

<http://model.geneontology.org/-488606272>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.org/dc/elements/1.1/source>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/-479090093> , <http://model.geneontology.org/-536289935> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1581>
] .

<http://model.geneontology.org/297447748>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/-536289935>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/531807246>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002333>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "enabled by" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/81580394> , <http://model.geneontology.org/138780236> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1585>
] .

<http://www.reactome.org/biopax/63/48887#Pathway1574>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Phosphoglucomutases 1 and 2 (PGM1, 2) are involved in the cytosolic biosynthesis of nucleotide sugars needed for glycan biosynthesis, specifically, the isomerisation of glucose-6-phosphate (G6P) into glucose-1-phosphate (G1P). Defects in PGM1 can cause congenital disorder of glycosylation 1t (CDG1t, now known as PGM1-CDG; MIM:614921), a broad spectrum disorder characterised by under-glycosylated serum glycoproteins (Timal et al. 2012, Tegtmeyer et al. 2014). CDGs result in a wide variety of clinical features such as defects in nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Defective PGM1 causes PGM1-CDG (CDG1t)" ;
        <http://geneontology.org/lego/hint/layout/x>
                5700 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Reviewed: Spillmann, Dorothe, 2015-04-30" , "https://reactome.org/content/detail/R-HSA-5609975" , "Authored: Jassal, Bijay, 2014-07-18" , "Edited: Jassal, Bijay, 2014-07-18" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/-292092767> , <http://model.geneontology.org/-234892925> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1575>
] .

<http://model.geneontology.org/-675603598>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://www.reactome.org/biopax/63/48887#Pathway1587>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://purl.obolibrary.org/obo/GO_0008150> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Sialuria (MIM:269921) is caused by a metabolic defect where the UDP?N?acetylglucosamine 2?epimerase, N?acetylmannosamine kinase (GNE) gene lacks feedback inhibition resulting in constitutive overproduction of free sialic acid (Neu5Ac) (Montreuil et al. 1968, Fontaine et al. 1968). Sialuria is characterised by a large cytoplasmic accumulation and urinary excretion of Neu5Ac (Kamerling et al. 1979). Sialurias differ from sialidoses, in which there is storage and excretion of 'bound' Neu5Ac. Defects in GNE also cause Nonaka myopathy (NK; MIM:605820), an early adult-onset disorder characterised by muscle weakness and wasting of distal muscles, especially the anterior tibial muscles (Nonaka et al. 1981, Asaka et al. 2001). Defects in GNE also cause inclusion body myopathy 2 (IBM2; MIM:600737), an autosomal recessive disorder with a similar phenotype to Nonaka myopathy (NK). IBM2 is an adult-onset, proximal and distal muscle weakness and wasting disorder. Muscle biospsy reveals from sufferers shows a rimmed vacuole myopathy and the degenerating muscle fibers contained abnormal amounts of beta-amyloid protein such as that found in neurodegenerative diorders. However, there is no neurological symptoms in these patients (Argov & Yarom 1984)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Defective GNE causes sialuria, Nonaka myopathy and inclusion body myopathy 2" ;
        <http://geneontology.org/lego/hint/layout/x>
                3100 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: Jassal, Bijay, 2013-08-01" , "Reviewed: Spillmann, Dorothe, 2015-04-30" , "Authored: Jassal, Bijay, 2013-08-01" , "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002233>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has input" .

<http://geneontology.org/lego/hint/layout/y>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://model.geneontology.org/-292092767>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://www.reactome.org/biopax/63/48887#Pathway1581>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://purl.obolibrary.org/obo/GO_0008150> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Glucosamine-fructose 6-phosphate aminotransferases 1 and 2 (GFPT1,2) are the first and rate-limiting enzymes in the hexosamine synthesis pathway, and thus formation of hexosamines like N-acetylglucosamine (GlcNAc). These enzymes probably play a role in limiting the availability of substrates for the N- and O-linked glycosylation of proteins. GFPT1 and 2 are required for normal functioning of neuromuscular synaptic transmission. Defects in GFPT1 lead to myasthenia, congenital, with tubular aggregates 1 (CMSTA1; MIM:610542), characterised by altered muscle fibre morphology and impaired neuromuscular junction development. Sufferers of CMSTA1 show a good response to acetylcholinesterase inhibitors (Senderek et al. 2011). The missense mutations observed do not always result in significant reduction in enzyme activity, but biopsies show reduced amounts of GFPT1 protein suggesting increased turnover or defective translation (Senderek et al. 2011)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Defective GFPT1 causes CMSTA1" ;
        <http://geneontology.org/lego/hint/layout/x>
                8950 , 9600 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 , 5900 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: Jassal, Bijay, 2013-08-01" , "https://reactome.org/content/detail/R-HSA-5609975" , "Reviewed: Spillmann, Dorothe, 2015-04-30" , "Edited: Jassal, Bijay, 2013-08-01" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/100934243>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/-95579262>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/-431406430>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/-675603598> , <http://model.geneontology.org/-732803440> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1580>
] .

<http://www.reactome.org/biopax/63/48887#Pathway1579>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Polyprenol reductase (SRD5A3), resident on the endoplasmic reticulum membrane, normally mediates the reduction of the alpha-isoprene unit of polyprenol (pPNOL) to form dolichol (DCHOL) in a NADPH-dependent manner (Cantagrel et al. 2010). DCHOLs are substrates required for the synthesis of the lipid-linked oligosaccharide (LLO) precursor used for N-glycosylation. Defects in SRD5A3 cause congenital disorder of glycosylation 1q (SRD5A3-CDG, CDG1q; MIM:612379), a neurodevelopmental disorder characterised by under-glycosylated serum glycoproteins resulting in nervous system development, psychomotor retardation, hypotonia, coagulation disorders and immunodeficiency (Cantagrel et al. 2010, Kasapkara et al. 2012). Defects in SRD5A3 can also cause Kahrizi syndrome (KHRZ; MIM:612713), a neurodevelopmental disorder characterised by mental retardation, cataracts, holes in eye structures, pathological curvature of the spine, and coarse facial features (Kahrizi et al. 2011)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Defective SRD5A3 causes SRD5A3-CDG (CDG-1q) and KHRZ" ;
        <http://geneontology.org/lego/hint/layout/x>
                1150 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: Jassal, B, 2013-10-25" , "Reviewed: Spillmann, Dorothe, 2015-04-30" , "https://reactome.org/content/detail/R-HSA-5609975" , "Authored: Jassal, B, 2013-10-25" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/138780236>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/728320751>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://www.reactome.org/biopax/63/48887#Pathway1532>
        a       <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Diseases of glycosylation, usually referred to as congenital disorders of glycosylation (CDG), are rare inherited disorders ascribing defects of nucleotide-sugar biosynthesis and transport, glycosyltransfer events and vesicular transport. Most CDGs cause neurological impairment ranging from severe psychomotor retardation to mild intellectual disability. Defects in N-glycosylation are the main cause of CDGs (Marquardt & Denecke 2003, Grunewald et al. 2002, Hennet 2012, Goreta et al. 2012) and can be identified by a characteristic abnormal isoelectric focusing profile of plasma transferrin (Jaeken et al. 1984, Stibler & Jaeken 1990). Disorders of O-glycosylation, glycosaminoglycan and glycolipid metabolism have recently been discovered and, together with N-glycosylation, represent the major pathways affected by glycan biosynthetic disorders (Freeze 2006, Jaeken 2011). As the number of these disorders has increased, nomenclature has been simplified so that now, the name of the mutant gene is followed by the abbreviation CDG (Jaeken et al. 2009). Effective therapies for most types of CDGs are so far not available (Thiel & Korner 2013)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Diseases of glycosylation" ;
        <http://geneontology.org/lego/hint/layout/x>
                2450 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: Jassal, B, 2013-06-28" , "Edited: Jassal, B, 2013-07-29" , "Reviewed: Spillmann, Dorothe, 2014-07-09" , "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/-57733269> , <http://model.geneontology.org/-114933111> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1584>
] .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/-431406430> , <http://model.geneontology.org/-488606272> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1574>
] .

<http://www.reactome.org/biopax/63/48887#Pathway1573>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.biopax.org/release/biopax-level3.owl#Pathway> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Glycosylation diseases associated with the enzymes that mediate the biosynthesis of glycosylation precursors are curated in this section (Jaeken & Matthijs 2007, Freeze et al. 2015)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Diseases associated with glycosylation precursor biosynthesis" ;
        <http://geneontology.org/lego/hint/layout/x>
                8950 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.obolibrary.org/obo/BFO_0000050>
                <http://www.reactome.org/biopax/63/48887#Pathway1532> ;
        <http://purl.obolibrary.org/obo/BFO_0000051>
                <http://www.reactome.org/biopax/63/48887#Pathway1577> , <http://www.reactome.org/biopax/63/48887#Pathway1574> , <http://www.reactome.org/biopax/63/48887#Pathway1582> , <http://www.reactome.org/biopax/63/48887#Pathway1586> , <http://www.reactome.org/biopax/63/48887#Pathway1576> , <http://www.reactome.org/biopax/63/48887#Pathway1579> , <http://www.reactome.org/biopax/63/48887#Pathway1588> , <http://www.reactome.org/biopax/63/48887#Pathway1581> , <http://www.reactome.org/biopax/63/48887#Pathway1584> , <http://www.reactome.org/biopax/63/48887#Pathway1585> , <http://www.reactome.org/biopax/63/48887#Pathway1575> , <http://www.reactome.org/biopax/63/48887#Pathway1578> , <http://www.reactome.org/biopax/63/48887#Pathway1587> , <http://www.reactome.org/biopax/63/48887#Pathway1580> , <http://www.reactome.org/biopax/63/48887#Pathway1583> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: Jassal, Bijay, 2014-07-18" , "https://reactome.org/content/detail/R-HSA-5609975" , "Edited: Jassal, Bijay, 2014-07-18" , "Reviewed: Spillmann, Dorothe, 2014-07-09" , "Reviewed: Timson, David J, 2015-02-25" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://www.reactome.org/biopax/63/48887#Pathway1586>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Dolichyl-phosphate mannosyltransferase (DPM), a heterotrimeric protein embedded in the endoplasmic reticulum membrane, mediates the transfer of mannose (from cytosolic GDP-mannose) to dolichyl phosphate (DOLP) to form dolichyl-phosphate-mannose (DOLPman). The first subunit of the heterotrimer (DPM1) appears to be the actual catalyst, and the other two subunits (DPM2 and 3) appear to stabilise it (Maeda et al. 2000). Defects in DPM3 can cause congenital disorder of glycosylation 1o (DPM3-CDG, CDG1o; MIM:612937), a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterised by under-glycosylated serum glycoproteins. CDG type 1 diseases result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency (Lefeber et al. 2009).<br><br>Four biosynthetic pathways depend on DOLPman; N-glycosylation, O-mannosylation, C-Mannosylation and GPI-anchor biosynthesis. A defect in DPM3 strongly reduces O-mannosylation of alpha-dystroglycan, explaining the clinical phenotype of muscular dystrophy and linking the congenital disorders of glycosylation with the dystroglycanopathies (Lefeber et al. 2009)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Defective DPM3 causes DPM3-CDG (CDG-1o)" ;
        <http://geneontology.org/lego/hint/layout/x>
                7000 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Reviewed: Spillmann, Dorothe, 2015-04-30" , "Edited: Jassal, B, 2013-10-18" , "https://reactome.org/content/detail/R-HSA-5609975" , "Authored: Jassal, B, 2013-10-18" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/-479090093>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/81580394>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://geneontology.org/lego/hint/layout/x>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://www.reactome.org/biopax/63/48887#Pathway1580>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.biopax.org/release/biopax-level3.owl#Pathway> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Dolichol kinase (DOLK, TMEM15) normally mediates the phosphorylation of dolichol (DCHOL) to form dolichyl phosphate (DOLP) in the ER membrane (Fernandez et al. 2002). DOLP is an important substrate in the synthesis of N- and O-glycosylated proteins and GPI anchors. Defects in DOLK cause congenital disorder of glycosylation type 1m (DOLK-CDG, CDG1m, also known as dolichol kinase deficiency; MIM:610768), a severe mutisystem disorder characterised by under-glycosylated serum glycoproteins. This disorder has a very severe phenotype and death can occur in early life (Kranz et al. 2007)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Defective DOLK causes DOLK-CDG (CDG-1m)" ;
        <http://geneontology.org/lego/hint/layout/x>
                8950 , 10900 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 , 6800 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: Jassal, B, 2013-10-25" , "Edited: Jassal, B, 2013-10-25" , "https://reactome.org/content/detail/R-HSA-5609975" , "Reviewed: Spillmann, Dorothe, 2015-04-30" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://geneontology.org/lego/evidence>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://model.geneontology.org/-114933111>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/474607404>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://www.biopax.org/release/biopax-level3.owl#Pathway>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Pathway" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/BFO_0000015> .

<http://purl.org/dc/elements/1.1/date>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://www.reactome.org/biopax/63/48887#Pathway1578>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.biopax.org/release/biopax-level3.owl#Pathway> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "The ER membrane-associated enzyme dehydrodolichyl diphosphate synthase (DHDDS) (Endo et al. 2003) normally mediates the sequential head-to-tail cis addition of multiple isopentyl pyrophosphate (IPP) molecules to farnesyl pyrophosphate (E,E-FPP) to produce polyprenol pyrophosphate (pPPP) (Shridas et al. 2003). Dolichol in humans contain homologues ranging from 17-23 isoprene units, the most common homologues contain 19 or 20 isoprene units (Freeman et al. 1980). Dolichol is an important substrate in the N-glycosylation of proteins, including rhodopsin.<br><br>Defects in DHDDS cause retinitis pigmentosa 59 (RP59; MIM:613861), a pigment retinopathy, characterised by retinal pigment deposits (visible on fundus examination) and primary loss of rod photoreceptors followed by secondary loss of cone photoreceptors. Sufferers typically have night vision blindness and loss of mid to peripheral vision. As the condition progresses, they lose far peripheral vision and eventually central vision (Zuchner et al. 2011)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Defective DHDDS causes retinitis pigmentosa 59" ;
        <http://geneontology.org/lego/hint/layout/x>
                500 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: Jassal, B, 2013-10-25" , "Edited: Jassal, B, 2013-10-25" , "https://reactome.org/content/detail/R-HSA-5609975" , "Reviewed: Spillmann, Dorothe, 2015-04-30" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/493961253> , <http://model.geneontology.org/551161095> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1579>
] .

<http://geneontology.org/lego/modelstate>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/CHEBI_33695>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "chebi gene" .

<http://purl.obolibrary.org/obo/RO_0001025>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "located in" .

<http://purl.obolibrary.org/obo/ECO_0000313>
        a       <http://www.w3.org/2002/07/owl#Class> .

<http://purl.obolibrary.org/obo/GO_0003674>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Molecular Function" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/-311446616> , <http://model.geneontology.org/-254246774> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1583>
] .

<http://model.geneontology.org/493961253>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002429>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "involved in positive regulation_of" .

<http://model.geneontology.org/-507960121>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/-400805559> , <http://model.geneontology.org/-458005401> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000050> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1532>
] .

<http://www.reactome.org/biopax/63/48887#Pathway1585>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0008150> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Dolichyl-phosphate mannosyltransferase (DPM), a heterotrimeric protein embedded in the endoplasmic reticulum membrane, mediates the transfer of mannose (from cytosolic GDP-mannose) to dolichyl phosphate (DOLP) to form dolichyl-phosphate-mannose (DOLPman). The first subunit of the heterotrimer (DPM1) appears to be the actual catalyst, and the other two subunits (DPM2 and 3) appear to stabilise it (Maeda et al. 2000). Defects in DPM2 can cause congenital disorder of glycosylation 1u (DPM2-CDG, CDG1u; MIM:615042), a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterised by under-glycosylated serum glycoproteins (Barone et al. 2012). CDG type 1 diseases result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Defective DPM2 causes DPM2-CDG (CDG-1u)" ;
        <http://geneontology.org/lego/hint/layout/x>
                5050 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Reviewed: Spillmann, Dorothe, 2015-04-30" , "https://reactome.org/content/detail/R-HSA-5609975" , "Authored: Jassal, B, 2013-10-18" , "Edited: Jassal, B, 2013-10-18" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002024>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly positively regulated by" .

<http://purl.obolibrary.org/obo/BFO_0000066>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "occurs in" .

<http://www.biopax.org/release/biopax-level3.owl#Reaction>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Reaction" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/BFO_0000015> .

<http://model.geneontology.org/278093899>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.org/dc/elements/1.1/contributor>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/RO_0002408>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly inhibits (process to process)" .

<http://model.geneontology.org/-57733269>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/728320751> , <http://model.geneontology.org/671120909> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1588>
] .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/297447748> , <http://model.geneontology.org/354647590> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1578>
] .

<http://www.reactome.org/biopax/63/48887#Pathway1577>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0008150> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Cytosolic galactokinase (GALK1) catalyses the first committed step in the Leloir pathway of galactose metabolism. GALK1 catalyses the phosphorylation of D-galactose (Gal) to form D-galactose 1-phosphate (Gal1P). Defects in GALK1 can cause type II galactosemia (GALCT2; MIM:230200), an autosomal recessive deficiency characterised by congenital cataracts during infancy and presenile cataracts in the adult population. Galactitol accumulation in the lens is the cause of these cataracts (Bosch et al. 2002)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Defective GALK1 can cause Galactosemia II (GALCT2)" ;
        <http://geneontology.org/lego/hint/layout/x>
                3750 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" , "Edited: Jassal, Bijay, 2014-07-18" , "Reviewed: Timson, David J, 2015-02-25" , "Authored: Jassal, Bijay, 2014-07-18" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002430>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "involved in negative regulation_of" .

<http://www.biopax.org/release/biopax-level3.owl#Protein>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Protein" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/BFO_0000002> .

<http://model.geneontology.org/-732803440>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:17506657" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/-507960121> , <http://model.geneontology.org/-450760279> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5609975" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-26" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1573> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1582>
] .

<http://purl.org/dc/elements/1.1/title>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/RO_0002428>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "involved in regulation of" .

<http://model.geneontology.org/-254246774>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:25840006" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://www.reactome.org/biopax/63/48887#Pathway1584>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.biopax.org/release/biopax-level3.owl#Pathway> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Dolichyl-phosphate mannosyltransferase (DPM), a heterotrimeric protein embedded in the endoplasmic reticulum membrane, mediates the transfer of mannose (from cytosolic GDP-mannose) to dolichyl phosphate (DOLP) to form dolichyl-phosphate-mannose (DOLPman). The first subunit of the heterotrimer (DPM1) appears to be the actual catalyst, and the other two subunits (DPM2 and 3) appear to stabilise it (Maeda et al. 2000). Defects in DPM1 can cause congenital disorder of glycosylation 1e (DPM1-CDG, CDG-1e; MIM:608799), a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterised by under-glycosylated serum glycoproteins (Kim et al. 2000, Imbach et al. 2000, Garcia-Silva et al. 2004)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Defective DPM1 causes DPM1-CDG (CDG-1e)" ;
        <http://geneontology.org/lego/hint/layout/x>
                8300 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: Jassal, B, 2013-10-17" , "Reviewed: Spillmann, Dorothe, 2015-04-30" , "Authored: Jassal, B, 2013-10-17" , "https://reactome.org/content/detail/R-HSA-5609975" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-26" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002023>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly negatively regulated by" .
